Game-changing HIV prevention drug must be available for $40 per year — everywhere Gilead must do more to ensure enough lenacapavir is available worldwide to turn the tide on the HIV/AIDS pandemic. Kate Rankin June 17 2026, 9:20am Gilead, which controls the production and distribution of this game-changing medicine, currently sells it at very high prices to a very limited set of countries, has severely restricted supply to low- and middle-income countries (LMICs), and refuses to sell it directly to MSF . Lenacapavir: Two Shots.